Shenzhen Hepalink Pharmaceutical Group Co Ltd Relative Valuation - Shenzhen Hepalink Pharmaceutical Group Co Ltd

Watchlist Manager

Watchlist

Price: 10.9 CNY -2.15%

Market Cap: 16B CNY

Section:

Relative Value

The Relative Value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 10.9 CNY, Shenzhen Hepalink Pharmaceutical Group Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

Shenzhen Hepalink Pharmaceutical Group Co Ltd Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

P/S

vs History	57
vs Industry	38

Median 5Y

3.2

Industry

2.4

Forward

2.9

More Details

24.7

P/E

vs History	74
vs Industry	8

Median 5Y

28.3

Industry

20.6

Forward

21.6

More Details

7.3

P/OCF

vs History	31
vs Industry	44

Median 5Y

-16.6

Industry

15.5

More Details

641.6

P/FCFE

vs History	3
vs Industry	16

Median 5Y

-10.5

Industry

More Details

1.3

P/B

vs History	79
vs Industry	52

Median 5Y

1.7

Industry

1.9

More Details

3.1

EV/S

vs History	63
vs Industry	38

Median 5Y

3.4

Industry

2.5

Forward

More Details

9.4

EV/GP

vs History	68
vs Industry	23

Median 5Y

10.6

Industry

4.9

More Details

25.3

EV/EBITDA

vs History	58
vs Industry	18

Median 5Y

27.2

Industry

12.6

Forward

14.1

More Details

25.3

EV/EBIT

vs History	58
vs Industry	22

Median 5Y

27.2

Industry

15.7

Forward

More Details

7.5

EV/OCF

vs History	31
vs Industry	45

Median 5Y

-18.8

Industry

More Details

8.2

EV/FCFF

vs History	22
vs Industry	34

Median 5Y

-20.9

Industry

17.7

More Details

1.1

EV/IC

vs History	63
vs Industry	53

Median 5Y

1.3

Industry

1.8

More Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN	S	Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399	16B CNY	3	24.7	25.3	25.3
US		Eli Lilly and Co NYSE:LLY	838.1B USD	18.6	79.1	45.9	50.7
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	578.3	-15 783.5	3 846.3	17 702.3
US		Johnson & Johnson NYSE:JNJ	372.1B USD	4.2	17.1	12.4	16.3
DK		Novo Nordisk A/S CSE:NOVO B	1.8T DKK	6.2	17.7	11.7	13.4
CH		Roche Holding AG SIX:ROG	208.3B CHF	3.4	25.2	9.5	11.1
CH		Novartis AG SIX:NOVN	187.4B CHF	4.4	19	11.5	14.7
UK		AstraZeneca PLC LSE:AZN	161.3B GBP	4	30.5	126.2	192.7
US		Merck & Co Inc NYSE:MRK	209.1B USD	3.3	12	8.6	10.3
IE	E	Endo International PLC LSE:0Y5F	163.5B USD	70.5	-56	261.3	655.3
FR		Sanofi SA PAR:SAN	115.8B EUR	1.3	9.1	5	5.9

				Revenue Growth	P/S to Growth
CN	S	Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399	Average P/S: 63.4 3	7%	0.4
US		Eli Lilly and Co NYSE:LLY	18.6	23%	0.8
UK		Dechra Pharmaceuticals PLC LSE:DPH	578.3	9%	64.3
US		Johnson & Johnson NYSE:JNJ	4.2	4%	1
DK		Novo Nordisk A/S CSE:NOVO B	6.2	16%	0.4
CH		Roche Holding AG SIX:ROG	3.4	5%	0.7
CH		Novartis AG SIX:NOVN	4.4	3%	1.5
UK		AstraZeneca PLC LSE:AZN	4	7%	0.6
US		Merck & Co Inc NYSE:MRK	3.3	5%	0.7
IE	E	Endo International PLC LSE:0Y5F	70.5	N/A	N/A
FR		Sanofi SA PAR:SAN	1.3	6%	0.2

				Earnings Growth	PEG
CN	S	Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399	Average P/E: 26.1 24.7	14%	1.8
US		Eli Lilly and Co NYSE:LLY	79.1	49%	1.6
UK		Dechra Pharmaceuticals PLC LSE:DPH	Negative Multiple: -15 783.5	N/A	N/A
US		Johnson & Johnson NYSE:JNJ	17.1	27%	0.6
DK		Novo Nordisk A/S CSE:NOVO B	17.7	18%	1
CH		Roche Holding AG SIX:ROG	25.2	32%	0.8
CH		Novartis AG SIX:NOVN	19	17%	1.1
UK		AstraZeneca PLC LSE:AZN	30.5	36%	0.8
US		Merck & Co Inc NYSE:MRK	12	18%	0.7
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -56	N/A	N/A
FR		Sanofi SA PAR:SAN	9.1	28%	0.3

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

	Bassett Furniture Industries Inc NASDAQ:BSET	17.77 USD -0.56%
	1-800-Flowers.Com Inc NASDAQ:FLWS	5.5 USD 1.48%
	SI-BONE Inc NASDAQ:SIBN	14.41 USD 0.14%
	Cogent Communications Holdings Inc NASDAQ:CCOI	53.53 USD 0.06%
S	Shanghai Kinetic Medical Co Ltd SZSE:300326	4.84 CNY -1.22%
S	Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399	10.9 CNY -2.15%

	Franklin Covey Co NYSE:FC	20.78 USD 0.19%
	Mohawk Industries Inc NYSE:MHK	106.87 USD -2.04%
	Ardmore Shipping Corp NYSE:ASC	9.58 USD 2.24%
	ASGN Inc NYSE:ASGN	51.37 USD -0.75%
	Skyworks Solutions Inc NASDAQ:SWKS	61.52 USD 0.03%
	Weatherford International PLC NASDAQ:WFRD	42.74 USD 3.14%

	Johnson & Johnson NYSE:JNJ	154.58 USD -0.23%
	Bank of America Corp NYSE:BAC	39.69 USD 0.28%
	Mastercard Inc NYSE:MA	533.48 USD -0.37%
	Salesforce Inc NYSE:CRM	267.85 USD 1.19%
	Abbvie Inc NYSE:ABBV	186.06 USD 3.15%
	Home Depot Inc NYSE:HD	357.58 USD -0.57%

	Arista Networks Inc NYSE:ANET	77.91 USD 3.48%
	Visa Inc NYSE:V	335.17 USD -0.16%
	Texas Pacific Land Corp NYSE:TPL	1 334.63 USD -0.09%
	KLA Corp NASDAQ:KLAC	694.61 USD 0.75%
	Manhattan Associates Inc NASDAQ:MANH	174.58 USD 0.21%
	Monolithic Power Systems Inc NASDAQ:MPWR	583.72 USD 0.51%

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Shenzhen Hepalink Pharmaceutical Group Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

				EBITDA Growth	EV/EBITDA to Growth
CN	S	Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399	Average EV/EBITDA: 396.7 25.3	30%	0.8
US		Eli Lilly and Co NYSE:LLY	45.9	31%	1.5
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	36%	106.8
US		Johnson & Johnson NYSE:JNJ	12.4	8%	1.6
DK		Novo Nordisk A/S CSE:NOVO B	11.7	14%	0.8
CH		Roche Holding AG SIX:ROG	9.5	6%	1.6
CH		Novartis AG SIX:NOVN	11.5	5%	2.3
UK		AstraZeneca PLC LSE:AZN	126.2	9%	14
US		Merck & Co Inc NYSE:MRK	8.6	9%	1
IE	E	Endo International PLC LSE:0Y5F	261.3	N/A	N/A
FR		Sanofi SA PAR:SAN	5	8%	0.6

				EBIT Growth	EV/EBIT to Growth
CN	S	Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399	Average EV/EBIT: 1 699.8 25.3	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	50.7	33%	1.5
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	98%	180.6
US		Johnson & Johnson NYSE:JNJ	16.3	12%	1.4
DK		Novo Nordisk A/S CSE:NOVO B	13.4	16%	0.8
CH		Roche Holding AG SIX:ROG	11.1	8%	1.4
CH		Novartis AG SIX:NOVN	14.7	8%	1.8
UK		AstraZeneca PLC LSE:AZN	192.7	21%	9.2
US		Merck & Co Inc NYSE:MRK	10.3	12%	0.9
IE	E	Endo International PLC LSE:0Y5F	655.3	N/A	N/A
FR		Sanofi SA PAR:SAN	5.9	14%	0.4

	ServiceNow Inc NYSE:NOW	945.26 USD 0.71%
	EOG Resources Inc NYSE:EOG	113.07 USD -0.34%
	Monster Beverage Corp NASDAQ:MNST	58.67 USD 0.14%
	Copart Inc NASDAQ:CPRT	60.9 USD -1.73%
	Applied Materials Inc NASDAQ:AMAT	151.55 USD 0.92%
	Airbnb Inc NASDAQ:ABNB	122.51 USD 0.66%

52 Week Range	8.27 12.29
Price Target

Shenzhen Hepalink Pharmaceutical Group Co Ltd SZSE:002399

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples Shenzhen Hepalink Pharmaceutical Group Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Competitors Multiples
Shenzhen Hepalink Pharmaceutical Group Co Ltd Competitors